Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Ahern

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nature Reviews. Endocrinology|February 23, 2010
Cancer: Risk of hypogonadism in male survivors of childhood cancerTomas Ahern, Frances J Hayes
Public Health Nutrition|January 27, 2010
BMI > or = 50 kg/m2 is associated with a younger age of onset of overweight and a high prevalence of adverse metabolic profilesJean O'Connell, Phillip Kieran, Kathleen Gorman, et al.
International Journal of Dermatology|July 23, 2013
The dermatological consequences of obesityAnne-Marie Tobin, Tomas Ahern, Sarah Rogers, et al.
International Journal of Dermatology|August 2, 2017
Adipokines, psoriasis, systemic inflammation, and endothelial dysfunctionMaeve Lynch, Tomas Ahern, Cheryl M Sweeney, et al.
Dermatology (Basel, Switzerland)|September 2, 2019
Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled TrialMaeve Lynch, Anna Malara, Irene Timoney, et al.
Dermatology (Basel, Switzerland)|April 18, 2021
Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical TrialMaeve Lynch, Anna Malara, Irene Timoney, et al.
Clinical Endocrinology|June 2, 2018
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMASGiulia Rastrelli, Terence W O'Neill, Tomas Ahern, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2015
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMASGiulia Rastrelli, Emma L Carter, Tomas Ahern, et al.
European Journal of Endocrinology|September 17, 2016
The androgen receptor gene CAG repeat 
in relation to 4-year changes in 
androgen-sensitive endpoints in 
community-dwelling older European menRobert J A H Eendebak, Ilpo T Huhtaniemi, Stephen R Pye, et al.
Clinical Endocrinology|November 28, 2017
Elevated luteinizing hormone despite normal testosterone levels in older men-natural history, risk factors and clinical featuresRobert J A H Eendebak, Tomas Ahern, Agnieszka Swiecicka, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nature Reviews. Endocrinology|February 23, 2010
Cancer: Risk of hypogonadism in male survivors of childhood cancerTomas Ahern, Frances J Hayes
Public Health Nutrition|January 27, 2010
BMI > or = 50 kg/m2 is associated with a younger age of onset of overweight and a high prevalence of adverse metabolic profilesJean O'Connell, Phillip Kieran, Kathleen Gorman, et al.
International Journal of Dermatology|July 23, 2013
The dermatological consequences of obesityAnne-Marie Tobin, Tomas Ahern, Sarah Rogers, et al.
International Journal of Dermatology|August 2, 2017
Adipokines, psoriasis, systemic inflammation, and endothelial dysfunctionMaeve Lynch, Tomas Ahern, Cheryl M Sweeney, et al.
Dermatology (Basel, Switzerland)|September 2, 2019
Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled TrialMaeve Lynch, Anna Malara, Irene Timoney, et al.
Dermatology (Basel, Switzerland)|April 18, 2021
Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical TrialMaeve Lynch, Anna Malara, Irene Timoney, et al.
Clinical Endocrinology|June 2, 2018
Symptomatic androgen deficiency develops only when both total and free testosterone decline in obese men who may have incident biochemical secondary hypogonadism: Prospective results from the EMASGiulia Rastrelli, Terence W O'Neill, Tomas Ahern, et al.
The Journal of Clinical Endocrinology and Metabolism|May 23, 2015
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMASGiulia Rastrelli, Emma L Carter, Tomas Ahern, et al.
European Journal of Endocrinology|September 17, 2016
The androgen receptor gene CAG repeat 
in relation to 4-year changes in 
androgen-sensitive endpoints in 
community-dwelling older European menRobert J A H Eendebak, Ilpo T Huhtaniemi, Stephen R Pye, et al.
Clinical Endocrinology|November 28, 2017
Elevated luteinizing hormone despite normal testosterone levels in older men-natural history, risk factors and clinical featuresRobert J A H Eendebak, Tomas Ahern, Agnieszka Swiecicka, et al.
Pageof 2